Dr. Mustafa Sardini, MD

Dr. Sardini practices at Baylor Scott & White Medical Center - Sunnyvale in Sunnyvale, Texas, part of Baylor Scott & White Health.

Dr. Sardini's NPI, 1891979175, was assigned on December 22, 2007. Dr. Sardini graduated from Damascus University Faculty of Medicine in 2002. Dr. Sardini's Texas license number on file is N1127.

Dr. Sardini's primary practice is Baylor Scott & White Medical Center - Sunnyvale, at 231 South Collins Road, Sunnyvale, TX 75182 in Dallas County. The practice phone is (972) 892-3000.

Dr. Sardini's primary practice is Baylor Scott & White Medical Center - Sunnyvale in Sunnyvale, Texas, part of Baylor Scott & White Health. Dr. Sardini is also affiliated with Hunt Regional Medical Center Greenville. The medical group on file is CHRISTUS Trinity Clinic. Dmand AI also links Dr. Sardini to 1 more hospital, 5 skilled nursing facilities, 3 medical groups, 2 hospices, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sardini practices, 12 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sardini's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sardini is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sardini's licenses on file in 3 states: Texas, Missouri and New Jersey.

Dmand AI lists acid reflux, arthritis, cardiac arrhythmia, chronic hypertension, chronic kidney disease, congestive heart failure, enlarged prostate and gastrointestinal bleeding among the conditions Dr. Sardini treats.

CMS data shows 3,639 Medicare services from Dr. Sardini across 9 procedure codes in 2024, for 460 Medicare patients. Medicare paid $339,754 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 460 Medicare patients who saw Dr. Sardini in 2024. The largest group is 75 to 84, with 158 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sardini's median patient age at 75, with 60% women.

In 2024, Dr. Sardini wrote 3,797 Medicare Part D claims for 387 patients. 88% of them were for generic drugs. CMS names the drug for 3,153 of them, across 83 drugs with 11 or more claims each, at $124,615 in total drug cost. In 2023, CMS named 337 claims across 13 drugs.

Dr. Sardini accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Dr. Sardini from 4 drug and device companies from 2018 to 2023. Consulting fees make up the largest share, 70% of the total. Gilead Sciences, Inc. paid the most, $1,570.

Dr. Sardini graduated from Damascus University Faculty of Medicine in 2002.

Dr. Sardini is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.